Abstract

Background and Aims: Methamphetamine (MA) abuse is commonly associated with the development of psychotic symptoms. The predictors and related risk factors of MA induced psychosis (MIP) are poorly understood. We investigated the occurrence of MIP, and analyzed the clinical features and possible risk factors among individuals with MA use disorderMethod: One thousand four hundred and thirty participants with MA use disorder were recruited from compulsory rehabilitation centers in Shanghai. A structured questionnaire including demographic characteristics, drug use history, visual analog scales, Beck Depression Inventory-13 (BDI-13), and Hamilton anxiety scale-14 (HAMA-14) were used to collect clinical related information. Fifty-six participants had accomplished the test of CogState Battery.Results: Among the 1430 individuals with MA use disorder, 37.1% were diagnosed as MIP according DSM-IV. There were significant differences in age, marital status, age of drug use onset, MA use years, Average MA use dose, interval of MA use, maximum dose, concurrent use of alcohol, and other drugs, VAS score, MA dependence, BDI-13 scores, HAMA-14 scores, verbal learning memory, and visual learning memory between the MIP group and the none MIP group (P < 0.05). The age of drug use onset (OR = 0.978, p = 0.011), average drug use dose (OR = 1.800, p = 0.015), craving score (OR = 1.069, p = 0.031), MA dependence (OR = 2.214, p < 0.001), and HAMA scores (OR = 1.028, p < 0.001) were associated to MIP.Conclusion: Individuals with MIP had more severe drug use problems, emotional symptoms and cognitive impairment. Earlier onset of drug use, higher quantity of drug use, higher craving, middle or severe drug use disorder and more anxiety symptoms may be related risk factors of MIP.

Highlights

  • Drug abuse is a global public health problem, which is supported by 275 million people worldwide utilizing drug at least once in 2016, according to the 2017 World Drug Report

  • A multivariate logistics regression analysis was carried, and the results showed that the age of drug use onset, Average MA use dose, craving score, MA dependence, and HAMA scores were the risk factors to MA induced Psychosis (MIP) (P < 0.05) (Table 4)

  • We found the a high prevalence of psychiatric symptoms in MA use disorder patients, and the participants with MIP were more severe drug use problems, emotional symptoms and cognitive impairment

Read more

Summary

Introduction

Drug abuse is a global public health problem, which is supported by 275 million people worldwide (about 5.6 percent of the population during the age of 15–64 years) utilizing drug at least once in 2016, according to the 2017 World Drug Report. In China, MA has been the most commonly used drug instead of heroin [2].The abuse of MA can cause a series of physiological and mental health problems, including sympathetic excitation, euphoria, energetic, alertness, suspicion, and psychiatric disorder [2]. Chen et al [5] compared the individuals with MA use disorder (n = 445), among them, there were 174 (39%) participants with a lifetime diagnosis of a MA-induced psychotic disorder; and 261 (59%) without MIP [5]. The psychiatric disorder which is caused by MA abusing was called MA induced Psychosis (MIP) [7]. We investigated the occurrence of MIP, and analyzed the clinical features and possible risk factors among individuals with MA use disorder

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call